{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T00:10:13Z","timestamp":1792800613391,"version":"4.5.0"},"reference-count":161,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T00:00:00Z","timestamp":1780531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T00:00:00Z","timestamp":1785715200000},"content-version":"vor","delay-in-days":60,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["12302411"],"award-info":[{"award-number":["12302411"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002858","name":"China Postdoctoral Science Foundation","doi-asserted-by":"publisher","award":["2025M772875"],"award-info":[{"award-number":["2025M772875"]}],"id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Shaanxi Province High-level Talent Cultivation Program, Shaanxi Provincial Health and Medical Research Innovation Capacity Enhancement Plan","award":["2025YF-32,2024PT-01"],"award-info":[{"award-number":["2025YF-32,2024PT-01"]}]},{"name":"Shaanxi Province Postdoctoral Research Program","award":["2024BSHSDZZ039"],"award-info":[{"award-number":["2024BSHSDZZ039"]}]},{"name":"the Wu JiePing Medical Foundation","award":["320.6750.2023-06-24"],"award-info":[{"award-number":["320.6750.2023-06-24"]}],"id":[{"id":"https:\/\/ror.org\/05dgwj702","id-type":"ROR","asserted-by":"crossref"}]},{"name":"Shaanxi Province Innovation Capability Support Plan","award":["2025ZC-KJXX-87,2024RS-CXTD-84"],"award-info":[{"award-number":["2025ZC-KJXX-87,2024RS-CXTD-84"]}]},{"name":"Xi'an Municipal Science and Technology Bureau General Program of Medical Research","award":["25YXYJYB00009"],"award-info":[{"award-number":["25YXYJYB00009"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Nanobiotechnol"],"DOI":"10.1186\/s12951-026-04629-2","type":"journal-article","created":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T04:04:50Z","timestamp":1780545890000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Iron-based magnetic nanoplatforms for immune microenvironment remodeling and cancer immunotherapy: progress and prospects"],"prefix":"10.1186","volume":"24","author":[{"given":"Le","family":"Chang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiqi","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cuixiang","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianhua","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,4]]},"reference":[{"issue":"8","key":"4629_CR1","doi-asserted-by":"publisher","first-page":"1627","DOI":"10.1016\/j.cell.2023.02.020","volume":"186","author":"DJ Kloosterman","year":"2023","unstructured":"Kloosterman DJ, et al. Macrophages at the interface of the co-evolving cancer ecosystem. Cell. 2023;186(8):1627\u201351. https:\/\/doi.org\/10.1016\/j.cell.2023.02.020.","journal-title":"Cell"},{"issue":"3","key":"4629_CR2","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1016\/j.ccell.2023.02.016","volume":"41","author":"KE de Visser","year":"2023","unstructured":"de Visser KE, et al. The evolving tumor microenvironment: from cancer initiation to metastatic outgrowth. Cancer Cell. 2023;41(3):374\u2013403. https:\/\/doi.org\/10.1016\/j.ccell.2023.02.016.","journal-title":"Cancer Cell"},{"issue":"1","key":"4629_CR3","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-025-02280-1","volume":"10","author":"M Tufail","year":"2025","unstructured":"Tufail M, et al. Immune evasion in cancer: mechanisms and cutting-edge therapeutic approaches. Signal Transduct Target Ther. 2025;10(1):227. https:\/\/doi.org\/10.1038\/s41392-025-02280-1.","journal-title":"Signal Transduct Target Ther"},{"issue":"2","key":"4629_CR4","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1038\/s41571-023-00846-y","volume":"21","author":"SA Lasser","year":"2024","unstructured":"Lasser SA, et al. Myeloid-derived suppressor cells in cancer and cancer therapy. Nat Rev Clin Oncol. 2024;21(2):147\u201364. https:\/\/doi.org\/10.1038\/s41571-023-00846-y.","journal-title":"Nat Rev Clin Oncol"},{"issue":"6","key":"4629_CR5","doi-asserted-by":"publisher","first-page":"1512","DOI":"10.1038\/s41588-025-02193-3","volume":"57","author":"M Oliveira","year":"2025","unstructured":"Oliveira M, et al. High-definition spatial transcriptomic profiling of immune cell populations in colorectal cancer. Nat Genet. 2025;57(6):1512\u201323. https:\/\/doi.org\/10.1038\/s41588-025-02193-3.","journal-title":"Nat Genet"},{"issue":"1","key":"4629_CR6","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-023-04600-x","volume":"21","author":"M Wang","year":"2023","unstructured":"Wang M, et al. Unraveling temporal and spatial biomarkers of epithelial-mesenchymal transition in colorectal cancer: insights into the crucial role of immunosuppressive cells. J Transl Med. 2023;21(1):794. https:\/\/doi.org\/10.1186\/s12967-023-04600-x.","journal-title":"J Transl Med"},{"key":"4629_CR7","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.844142","volume":"13","author":"B Lv","year":"2022","unstructured":"Lv B, et al. Immunotherapy: reshape the tumor immune microenvironment. Front Immunol. 2022;13:844142. https:\/\/doi.org\/10.3389\/fimmu.2022.844142.","journal-title":"Front Immunol"},{"issue":"8","key":"4629_CR8","doi-asserted-by":"publisher","first-page":"5420","DOI":"10.1097\/js9.0000000000002636","volume":"111","author":"T Ren","year":"2025","unstructured":"Ren T, et al. Mechanical forces and immune cells in the tumor microenvironment: from regulation mechanisms to therapeutic strategies. Int J Surg. 2025;111(8):5420\u201334. https:\/\/doi.org\/10.1097\/js9.0000000000002636.","journal-title":"Int J Surg"},{"issue":"1","key":"4629_CR9","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-024-01979-x","volume":"9","author":"B Wu","year":"2024","unstructured":"Wu B, et al. Cold and hot tumors: from molecular mechanisms to targeted therapy. Signal Transduct Target Ther. 2024;9(1):274. https:\/\/doi.org\/10.1038\/s41392-024-01979-x.","journal-title":"Signal Transduct Target Ther"},{"issue":"8","key":"4629_CR10","doi-asserted-by":"publisher","first-page":"1652","DOI":"10.1016\/j.cell.2023.03.006","volume":"186","author":"P Sharma","year":"2023","unstructured":"Sharma P, et al. Immune checkpoint therapy\u2014current perspectives and future directions. Cell. 2023;186(8):1652\u201369. https:\/\/doi.org\/10.1016\/j.cell.2023.03.006.","journal-title":"Cell"},{"issue":"4","key":"4629_CR11","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1038\/s41417-025-00886-9","volume":"32","author":"A Ibrahim","year":"2025","unstructured":"Ibrahim A, et al. MDSC checkpoint blockade therapy: a new breakthrough point overcoming immunosuppression in cancer immunotherapy. Cancer Gene Ther. 2025;32(4):371\u201392. https:\/\/doi.org\/10.1038\/s41417-025-00886-9.","journal-title":"Cancer Gene Ther"},{"issue":"1","key":"4629_CR12","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-025-02443-2","volume":"24","author":"C Yang","year":"2025","unstructured":"Yang C, et al. Engineered iron oxide nanoplatforms: reprogramming immunosuppressive niches for precision cancer theranostics. Mol Cancer. 2025;24(1):225. https:\/\/doi.org\/10.1186\/s12943-025-02443-2.","journal-title":"Mol Cancer"},{"key":"4629_CR13","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.bioactmat.2023.09.015","volume":"32","author":"MJ Ko","year":"2024","unstructured":"Ko MJ, et al. Magnetic nanoparticles for ferroptosis cancer therapy with diagnostic imaging. Bioact Mater. 2024;32:66\u201397. https:\/\/doi.org\/10.1016\/j.bioactmat.2023.09.015.","journal-title":"Bioact Mater"},{"issue":"1","key":"4629_CR14","doi-asserted-by":"publisher","DOI":"10.1186\/s12951-025-03488-7","volume":"23","author":"C-H Hsiao","year":"2025","unstructured":"Hsiao C-H, et al. Nano-orchestrated magnetotactic-like navigation for electromagnetic theranostics and immune enhancement via photoautotrophic oxygenation, mild hyperthermia, and ferroptosis. J Nanobiotechnol. 2025;23(1):442. https:\/\/doi.org\/10.1186\/s12951-025-03488-7.","journal-title":"J Nanobiotechnol"},{"key":"4629_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/j.addr.2023.114822","volume":"197","author":"R Qiao","year":"2023","unstructured":"Qiao R, et al. Magnetic iron oxide nanoparticles for brain imaging and drug delivery. Adv Drug Deliv Rev. 2023;197:114822. https:\/\/doi.org\/10.1016\/j.addr.2023.114822.","journal-title":"Adv Drug Deliv Rev"},{"issue":"15","key":"4629_CR16","doi-asserted-by":"publisher","first-page":"11587","DOI":"10.1039\/d5ra00728c","volume":"15","author":"R Ghazi","year":"2025","unstructured":"Ghazi R, et al. Iron oxide based magnetic nanoparticles for hyperthermia, MRI and drug delivery applications: a review. RSC Adv. 2025;15(15):11587\u2013616. https:\/\/doi.org\/10.1039\/d5ra00728c.","journal-title":"RSC Adv"},{"issue":"3","key":"4629_CR17","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1038\/s44222-024-00257-3","volume":"3","author":"A Shakeri-Zadeh","year":"2025","unstructured":"Shakeri-Zadeh A, et al. Imaging-guided precision hyperthermia with magnetic nanoparticles. Nat Rev Bioeng. 2025;3(3):245\u201360. https:\/\/doi.org\/10.1038\/s44222-024-00257-3.","journal-title":"Nat Rev Bioeng"},{"key":"4629_CR18","doi-asserted-by":"publisher","DOI":"10.1038\/s41422-025-01217-1","author":"Y Li","year":"2026","unstructured":"Li Y, et al. Dynamic magneto-mechanical force in lysosomes induces durable macrophage repolarization for antitumor immunity. Cell Res. 2026. https:\/\/doi.org\/10.1038\/s41422-025-01217-1.","journal-title":"Cell Res"},{"issue":"3","key":"4629_CR19","doi-asserted-by":"publisher","DOI":"10.1016\/j.celbio.2025.100222","volume":"2","author":"Z Wang","year":"2026","unstructured":"Wang Z, et al. Nanotechnology for tumor ferroptosis. Cell Biomaterials. 2026;2(3):100222. https:\/\/doi.org\/10.1016\/j.celbio.2025.100222.","journal-title":"Cell Biomaterials"},{"issue":"4","key":"4629_CR20","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1021\/cbmi.3c00026","volume":"1","author":"Z Li","year":"2023","unstructured":"Li Z, et al. Designing smart iron oxide nanoparticles for MR imaging of tumors. Chemical & Biomedical Imaging. 2023;1(4):315\u201339. https:\/\/doi.org\/10.1021\/cbmi.3c00026.","journal-title":"Chemical & Biomedical Imaging"},{"issue":"32","key":"4629_CR21","doi-asserted-by":"publisher","DOI":"10.1002\/adfm.202401654","volume":"34","author":"S Anand","year":"2024","unstructured":"Anand S, et al. Embracing remote fields as the fourth dimension of tissue biofabrication. Adv Funct Mater. 2024;34(32):2401654. https:\/\/doi.org\/10.1002\/adfm.202401654.","journal-title":"Adv Funct Mater"},{"key":"4629_CR22","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1016\/j.actbio.2023.02.033","volume":"161","author":"C Yao","year":"2023","unstructured":"Yao C, et al. Magneto-mechanical therapeutic effects and associated cell death pathways of magnetic nanocomposites with distinct geometries. Acta Biomater. 2023;161:238\u201349. https:\/\/doi.org\/10.1016\/j.actbio.2023.02.033.","journal-title":"Acta Biomater"},{"key":"4629_CR23","doi-asserted-by":"publisher","DOI":"10.1016\/j.cej.2024.154470","volume":"497","author":"J Yang","year":"2024","unstructured":"Yang J, et al. A hollow mesoporous iron oxide nanoparticle to strengthen Fenton reaction and weaken antioxidant defense systems for high efficacy tumor ferroptosis therapy. Chem Eng J. 2024;497:154470. https:\/\/doi.org\/10.1016\/j.cej.2024.154470.","journal-title":"Chem Eng J"},{"issue":"5","key":"4629_CR24","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1016\/j.trecan.2024.01.013","volume":"10","author":"E Catanzaro","year":"2024","unstructured":"Catanzaro E, et al. Immunogenicity of ferroptosis in cancer: a matter of context? Trends Cancer. 2024;10(5):407\u201316. https:\/\/doi.org\/10.1016\/j.trecan.2024.01.013.","journal-title":"Trends Cancer"},{"issue":"12","key":"4629_CR25","doi-asserted-by":"publisher","first-page":"910","DOI":"10.1038\/s41568-025-00864-1","volume":"25","author":"A Wahida","year":"2025","unstructured":"Wahida A, et al. Decoding ferroptosis for cancer therapy. Nat Rev Cancer. 2025;25(12):910\u201324. https:\/\/doi.org\/10.1038\/s41568-025-00864-1.","journal-title":"Nat Rev Cancer"},{"issue":"20","key":"4629_CR26","doi-asserted-by":"publisher","first-page":"3874","DOI":"10.1016\/j.molcel.2025.09.007","volume":"85","author":"R Chen","year":"2025","unstructured":"Chen R, et al. DAMPs in the immunogenicity of cell death. Mol Cell. 2025;85(20):3874\u201389. https:\/\/doi.org\/10.1016\/j.molcel.2025.09.007.","journal-title":"Mol Cell"},{"issue":"1","key":"4629_CR27","doi-asserted-by":"publisher","DOI":"10.1002\/wnan.70001","volume":"17","author":"L Wang","year":"2025","unstructured":"Wang L, et al. Iron-based nanomaterials for modulating tumor microenvironment. Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2025;17(1):e70001. https:\/\/doi.org\/10.1002\/wnan.70001.","journal-title":"Wiley Interdiscip Rev Nanomed Nanobiotechnol"},{"key":"4629_CR28","doi-asserted-by":"publisher","DOI":"10.1016\/j.colsurfb.2024.114070","volume":"241","author":"L Gan","year":"2024","unstructured":"Gan L, et al. A Fe(2)O(3)\/CNx cascade nanoreactor with dual-enzyme-mimetic activities for cancer hypoxia relief to amplify chemo\/photodynamic therapy. Colloids Surf B Biointerfaces. 2024;241:114070. https:\/\/doi.org\/10.1016\/j.colsurfb.2024.114070.","journal-title":"Colloids Surf B Biointerfaces"},{"issue":"5","key":"4629_CR29","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1038\/s41423-023-00990-6","volume":"20","author":"A Del Prete","year":"2023","unstructured":"Del Prete A, et al. Dendritic cell subsets in cancer immunity and tumor antigen sensing. Cell Mol Immunol. 2023;20(5):432\u201347. https:\/\/doi.org\/10.1038\/s41423-023-00990-6.","journal-title":"Cell Mol Immunol"},{"key":"4629_CR30","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpx.2025.100400","volume":"10","author":"S Xiang","year":"2025","unstructured":"Xiang S, et al. Breaking hypoxic barrier: oxygen-supplied nanomaterials for enhanced T cell-mediated tumor immunotherapy. Int J Pharm X. 2025;10:100400. https:\/\/doi.org\/10.1016\/j.ijpx.2025.100400.","journal-title":"Int J Pharm X"},{"key":"4629_CR31","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1739154","volume":"16","author":"K Zhang","year":"2026","unstructured":"Zhang K, et al. Macrophage-derived chemokines in T cell regulation: implications for cancer immunotherapy. Front Immunol. 2026;16:1739154. https:\/\/doi.org\/10.3389\/fimmu.2025.1739154.","journal-title":"Front Immunol"},{"issue":"10","key":"4629_CR32","doi-asserted-by":"publisher","first-page":"9209","DOI":"10.1021\/acsnano.3c00004","volume":"17","author":"B Yan","year":"2023","unstructured":"Yan B, et al. Reversal of HMGA1-mediated immunosuppression synergizes with immunogenic magnetothermodynamic for improved hepatocellular carcinoma therapy. ACS Nano. 2023;17(10):9209\u201323. https:\/\/doi.org\/10.1021\/acsnano.3c00004.","journal-title":"ACS Nano"},{"issue":"1","key":"4629_CR33","doi-asserted-by":"publisher","DOI":"10.1186\/s12951-024-02734-8","volume":"22","author":"M Li","year":"2024","unstructured":"Li M, et al. Magnetothermal-activated gene editing strategy for enhanced tumor cell apoptosis. J Nanobiotechnol. 2024;22(1):450. https:\/\/doi.org\/10.1186\/s12951-024-02734-8.","journal-title":"J Nanobiotechnol"},{"key":"4629_CR34","doi-asserted-by":"publisher","first-page":"373","DOI":"10.2147\/ijn.S14613","volume":"6","author":"HL Rodr\u00edguez-Luccioni","year":"2011","unstructured":"Rodr\u00edguez-Luccioni HL, et al. Enhanced reduction in cell viability by hyperthermia induced by magnetic nanoparticles. Int J Nanomedicine. 2011;6:373\u201380. https:\/\/doi.org\/10.2147\/ijn.S14613.","journal-title":"Int J Nanomedicine"},{"key":"4629_CR35","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2022.121799","volume":"289","author":"H Jiang","year":"2022","unstructured":"Jiang H, et al. Evoking tumor associated macrophages by mitochondria-targeted magnetothermal immunogenic cell death for cancer immunotherapy. Biomaterials. 2022;289:121799. https:\/\/doi.org\/10.1016\/j.biomaterials.2022.121799.","journal-title":"Biomaterials"},{"issue":"8","key":"4629_CR36","doi-asserted-by":"publisher","first-page":"8811","DOI":"10.1021\/acsnano.9b01979","volume":"13","author":"X Liu","year":"2019","unstructured":"Liu X, et al. Ferrimagnetic vortex nanoring-mediated mild magnetic hyperthermia imparts potent immunological effect for treating cancer metastasis. ACS Nano. 2019;13(8):8811\u201325. https:\/\/doi.org\/10.1021\/acsnano.9b01979.","journal-title":"ACS Nano"},{"issue":"4","key":"4629_CR37","doi-asserted-by":"publisher","first-page":"1454","DOI":"10.7150\/thno.80821","volume":"13","author":"A Hu","year":"2023","unstructured":"Hu A, et al. Controlled intracellular aggregation of magnetic particles improves permeation and retention for magnetic hyperthermia promotion and immune activation. Theranostics. 2023;13(4):1454\u201369. https:\/\/doi.org\/10.7150\/thno.80821.","journal-title":"Theranostics"},{"issue":"20","key":"4629_CR38","doi-asserted-by":"publisher","DOI":"10.1002\/adhm.202500260","volume":"14","author":"M Kaneko","year":"2025","unstructured":"Kaneko M, et al. All-in-one magnetic nanoparticles for thermo-immunotherapy of malignant melanoma. Adv Healthc Mater. 2025;14(20):e2500260. https:\/\/doi.org\/10.1002\/adhm.202500260.","journal-title":"Adv Healthc Mater"},{"issue":"12","key":"4629_CR39","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrp.2025.102977","volume":"6","author":"M Zha","year":"2025","unstructured":"Zha M, et al. Repurposing clinical iron oxide agents for mild hyperthermia-assisted cancer therapy. Cell Rep Phys Sci. 2025;6(12):102977. https:\/\/doi.org\/10.1016\/j.xcrp.2025.102977.","journal-title":"Cell Rep Phys Sci"},{"issue":"5","key":"4629_CR40","doi-asserted-by":"publisher","DOI":"10.3390\/cancers15051394","volume":"15","author":"P Vaupel","year":"2023","unstructured":"Vaupel P, et al. From localized mild hyperthermia to improved tumor oxygenation: physiological mechanisms critically involved in oncologic thermo-radio-immunotherapy. Cancers (Basel). 2023;15(5):1394. https:\/\/doi.org\/10.3390\/cancers15051394.","journal-title":"Cancers (Basel)"},{"key":"4629_CR41","doi-asserted-by":"publisher","DOI":"10.1007\/s10565-026-10160-9","author":"B Li","year":"2026","unstructured":"Li B, et al. Sublethal heat stress synergizes with the tumor microenvironment to drive recurrence of hepatocellular carcinoma after thermal ablation: mechanisms, molecular predictors, and targeted interventions. Cell Biol Toxicol. 2026. https:\/\/doi.org\/10.1007\/s10565-026-10160-9.","journal-title":"Cell Biol Toxicol"},{"issue":"4","key":"4629_CR42","doi-asserted-by":"publisher","DOI":"10.3390\/magnetochemistry11040033","volume":"11","author":"Y Mi","year":"2025","unstructured":"Mi Y, et al. Decaying oscillating pulsed magnetic field induces lysosome-dependent cell death in A375 melanoma via magneto-mechanical force. Magnetochemistry. 2025;11(4):33. https:\/\/doi.org\/10.3390\/magnetochemistry11040033.","journal-title":"Magnetochemistry"},{"key":"4629_CR43","doi-asserted-by":"publisher","DOI":"10.1016\/j.cej.2024.158311","volume":"503","author":"D Lee","year":"2025","unstructured":"Lee D, et al. Zinc ferrite nanoparticle with enhanced magnetic attraction for controlled drug delivery and in vivo tumor therapy. Chem Eng J. 2025;503:158311. https:\/\/doi.org\/10.1016\/j.cej.2024.158311.","journal-title":"Chem Eng J"},{"issue":"42","key":"4629_CR44","doi-asserted-by":"publisher","first-page":"19715","DOI":"10.1039\/D4NR00240G","volume":"16","author":"PS Patrick","year":"2024","unstructured":"Patrick PS, et al. Improved tumour delivery of iron oxide nanoparticles for magnetic hyperthermia therapy of melanoma via ultrasound guidance and 111In SPECT quantification. Nanoscale. 2024;16(42):19715\u201329. https:\/\/doi.org\/10.1039\/D4NR00240G.","journal-title":"Nanoscale"},{"issue":"6","key":"4629_CR45","doi-asserted-by":"publisher","first-page":"1735","DOI":"10.7150\/thno.18352","volume":"7","author":"Y Shen","year":"2017","unstructured":"Shen Y, et al. Elongated nanoparticle aggregates in cancer cells for mechanical destruction with low frequency rotating magnetic field. Theranostics. 2017;7(6):1735\u201348. https:\/\/doi.org\/10.7150\/thno.18352.","journal-title":"Theranostics"},{"issue":"4","key":"4629_CR46","doi-asserted-by":"publisher","first-page":"3192","DOI":"10.1021\/nn406302j","volume":"8","author":"E Zhang","year":"2014","unstructured":"Zhang E, et al. Dynamic magnetic fields remote-control apoptosis via nanoparticle rotation. ACS Nano. 2014;8(4):3192\u2013201. https:\/\/doi.org\/10.1021\/nn406302j.","journal-title":"ACS Nano"},{"issue":"47","key":"4629_CR47","doi-asserted-by":"publisher","DOI":"10.1002\/adma.202412730","volume":"36","author":"Y Xing","year":"2024","unstructured":"Xing Y, et al. Lysosome targeted nanoparticle aggregation reverses immunosuppressive tumor microenvironment for cancer immunotherapy. Adv Mater. 2024;36(47):e2412730. https:\/\/doi.org\/10.1002\/adma.202412730.","journal-title":"Adv Mater"},{"issue":"1","key":"4629_CR48","doi-asserted-by":"publisher","DOI":"10.1186\/s13046-023-02938-0","volume":"43","author":"J Da Silva","year":"2024","unstructured":"Da Silva J, et al. Radiotherapy-activated NBTXR3 nanoparticles promote ferroptosis through induction of lysosomal membrane permeabilization. J Exp Clin Cancer Res. 2024;43(1):11. https:\/\/doi.org\/10.1186\/s13046-023-02938-0.","journal-title":"J Exp Clin Cancer Res"},{"key":"4629_CR49","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1016\/j.jconrel.2024.07.041","volume":"373","author":"J Wang","year":"2024","unstructured":"Wang J, et al. Polyhedral magnetic nanoparticles induce apoptosis in gastric cancer stem cells and suppressing tumor growth through magnetic force generation. J Control Release. 2024;373:370\u201384. https:\/\/doi.org\/10.1016\/j.jconrel.2024.07.041.","journal-title":"J Control Release"},{"issue":"2","key":"4629_CR50","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1038\/nmat2591","volume":"9","author":"DH Kim","year":"2010","unstructured":"Kim DH, et al. Biofunctionalized magnetic-vortex microdiscs for targeted cancer-cell destruction. Nat Mater. 2010;9(2):165\u201371. https:\/\/doi.org\/10.1038\/nmat2591.","journal-title":"Nat Mater"},{"issue":"10","key":"4629_CR51","doi-asserted-by":"publisher","first-page":"1508","DOI":"10.1039\/d1tb02721b","volume":"10","author":"J Yao","year":"2022","unstructured":"Yao J, et al. Nanoplatform-mediated calcium overload for cancer therapy. J Mater Chem B. 2022;10(10):1508\u201319. https:\/\/doi.org\/10.1039\/d1tb02721b.","journal-title":"J Mater Chem B"},{"key":"4629_CR52","doi-asserted-by":"publisher","first-page":"6205","DOI":"10.2147\/ijn.S312752","volume":"16","author":"SH Hussein-Al-Ali","year":"2021","unstructured":"Hussein-Al-Ali SH, et al. Chlorambucil-iron oxide nanoparticles as a drug delivery system for leukemia cancer cells. Int J Nanomedicine. 2021;16:6205\u201316. https:\/\/doi.org\/10.2147\/ijn.S312752.","journal-title":"Int J Nanomedicine"},{"key":"4629_CR53","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2025.117901","volume":"184","author":"W Xu","year":"2025","unstructured":"Xu W, et al. Recent advances in chemodynamic nanotherapeutics to overcome multidrug resistance in cancers. Biomed Pharmacother. 2025;184:117901. https:\/\/doi.org\/10.1016\/j.biopha.2025.117901.","journal-title":"Biomed Pharmacother"},{"key":"4629_CR54","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics15092337","author":"R Ou","year":"2023","unstructured":"Ou R, et al. Advancements in the application of the Fenton reaction in the cancer microenvironment. Pharmaceutics. 2023. https:\/\/doi.org\/10.3390\/pharmaceutics15092337.","journal-title":"Pharmaceutics"},{"issue":"5","key":"4629_CR55","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1016\/j.cell.2012.03.042","volume":"149","author":"SJ Dixon","year":"2012","unstructured":"Dixon SJ, et al. Ferroptosis: an iron-dependent form of nonapoptotic cell death. Cell. 2012;149(5):1060\u201372. https:\/\/doi.org\/10.1016\/j.cell.2012.03.042.","journal-title":"Cell"},{"issue":"3","key":"4629_CR56","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/j.tcb.2015.10.014","volume":"26","author":"WS Yang","year":"2016","unstructured":"Yang WS, et al. Ferroptosis: death by lipid peroxidation. Trends Cell Biol. 2016;26(3):165\u201376. https:\/\/doi.org\/10.1016\/j.tcb.2015.10.014.","journal-title":"Trends Cell Biol"},{"issue":"14","key":"4629_CR57","doi-asserted-by":"publisher","first-page":"2401","DOI":"10.1016\/j.cell.2022.06.003","volume":"185","author":"BR Stockwell","year":"2022","unstructured":"Stockwell BR. Ferroptosis turns 10: emerging mechanisms, physiological functions, and therapeutic applications. Cell. 2022;185(14):2401\u201321. https:\/\/doi.org\/10.1016\/j.cell.2022.06.003.","journal-title":"Cell"},{"key":"4629_CR58","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2023.122333","volume":"302","author":"Z Feng","year":"2023","unstructured":"Feng Z, et al. An acid-responsive MOF nanomedicine for augmented anti-tumor immunotherapy via a metal ion interference-mediated pyroptotic pathway. Biomaterials. 2023;302:122333. https:\/\/doi.org\/10.1016\/j.biomaterials.2023.122333.","journal-title":"Biomaterials"},{"key":"4629_CR59","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijbiomac.2023.126323","volume":"251","author":"T Liu","year":"2023","unstructured":"Liu T, et al. Polyporus umbellatus polysaccharide iron-based nanocomposite for synergistic M1 polarization of TAMs and combinational anti-breast cancer therapy. Int J Biol Macromol. 2023;251:126323. https:\/\/doi.org\/10.1016\/j.ijbiomac.2023.126323.","journal-title":"Int J Biol Macromol"},{"issue":"7","key":"4629_CR60","doi-asserted-by":"publisher","first-page":"1030","DOI":"10.1016\/j.molcel.2023.03.005","volume":"83","author":"SJ Dixon","year":"2023","unstructured":"Dixon SJ, et al. Ferroptosis: a flexible constellation of related biochemical mechanisms. Mol Cell. 2023;83(7):1030\u201342. https:\/\/doi.org\/10.1016\/j.molcel.2023.03.005.","journal-title":"Mol Cell"},{"issue":"6","key":"4629_CR61","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1038\/s41580-024-00703-5","volume":"25","author":"SJ Dixon","year":"2024","unstructured":"Dixon SJ, et al. The cell biology of ferroptosis. Nat Rev Mol Cell Biol. 2024;25(6):424\u201342. https:\/\/doi.org\/10.1038\/s41580-024-00703-5.","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"8067","key":"4629_CR62","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1038\/s41586-025-08974-4","volume":"642","author":"T Ca\u00f1eque","year":"2025","unstructured":"Ca\u00f1eque T, et al. Activation of lysosomal iron triggers ferroptosis in cancer. Nature. 2025;642(8067):492\u2013500. https:\/\/doi.org\/10.1038\/s41586-025-08974-4.","journal-title":"Nature"},{"issue":"7860","key":"4629_CR63","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1038\/s41586-021-03539-7","volume":"593","author":"C Mao","year":"2021","unstructured":"Mao C, et al. DHODH-mediated ferroptosis defence is a targetable vulnerability in cancer. Nature. 2021;593(7860):586\u201390. https:\/\/doi.org\/10.1038\/s41586-021-03539-7.","journal-title":"Nature"},{"issue":"1","key":"4629_CR64","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1111\/imr.13235","volume":"321","author":"D Tang","year":"2024","unstructured":"Tang D, et al. Ferroptosis in immunostimulation and immunosuppression. Immunol Rev. 2024;321(1):199\u2013210. https:\/\/doi.org\/10.1111\/imr.13235.","journal-title":"Immunol Rev"},{"issue":"1","key":"4629_CR65","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-31218-2","volume":"13","author":"B Wiernicki","year":"2022","unstructured":"Wiernicki B, et al. Cancer cells dying from ferroptosis impede dendritic cell-mediated anti-tumor immunity. Nat Commun. 2022;13(1):3676. https:\/\/doi.org\/10.1038\/s41467-022-31218-2.","journal-title":"Nat Commun"},{"issue":"3","key":"4629_CR66","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1038\/nrc2344","volume":"8","author":"RG Bristow","year":"2008","unstructured":"Bristow RG, et al. Hypoxia and metabolism. Hypoxia, DNA repair and genetic instability. Nat Rev Cancer. 2008;8(3):180\u201392. https:\/\/doi.org\/10.1038\/nrc2344.","journal-title":"Nat Rev Cancer"},{"issue":"4","key":"4629_CR67","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1038\/s42255-019-0045-8","volume":"1","author":"Y Ye","year":"2019","unstructured":"Ye Y, et al. Characterization of hypoxia-associated molecular features to aid hypoxia-targeted therapy. Nat Metab. 2019;1(4):431\u201344. https:\/\/doi.org\/10.1038\/s42255-019-0045-8.","journal-title":"Nat Metab"},{"issue":"1","key":"4629_CR68","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-023-01332-8","volume":"8","author":"Z Chen","year":"2023","unstructured":"Chen Z, et al. Hypoxic microenvironment in cancer: molecular mechanisms and therapeutic interventions. Signal Transduct Target Ther. 2023;8(1):70. https:\/\/doi.org\/10.1038\/s41392-023-01332-8.","journal-title":"Signal Transduct Target Ther"},{"issue":"8","key":"4629_CR69","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1002\/ajh.21745","volume":"85","author":"A Raza","year":"2010","unstructured":"Raza A, et al. Pericytes and vessel maturation during tumor angiogenesis and metastasis. Am J Hematol. 2010;85(8):593\u20138. https:\/\/doi.org\/10.1002\/ajh.21745.","journal-title":"Am J Hematol"},{"issue":"3","key":"4629_CR70","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1038\/s44318-024-00319-7","volume":"44","author":"H Estephan","year":"2025","unstructured":"Estephan H, et al. Hypoxia promotes tumor immune evasion by suppressing MHC-I expression and antigen presentation. EMBO J. 2025;44(3):903\u201322. https:\/\/doi.org\/10.1038\/s44318-024-00319-7.","journal-title":"EMBO J"},{"issue":"11","key":"4629_CR71","doi-asserted-by":"publisher","first-page":"2439","DOI":"10.1084\/jem.20100587","volume":"207","author":"CA Corzo","year":"2010","unstructured":"Corzo CA, et al. HIF-1\u03b1 regulates function and differentiation of myeloid-derived suppressor cells in the tumor microenvironment. J Exp Med. 2010;207(11):2439\u201353. https:\/\/doi.org\/10.1084\/jem.20100587.","journal-title":"J Exp Med"},{"issue":"1","key":"4629_CR72","doi-asserted-by":"publisher","DOI":"10.1186\/s12951-024-02921-7","volume":"22","author":"Y Chen","year":"2024","unstructured":"Chen Y, et al. Iron-based MOF with catalase-like activity improves the synergistic therapeutic effect of PDT\/ferroptosis\/starvation therapy by reversing the tumor hypoxic microenvironment. J Nanobiotechnol. 2024;22(1):705. https:\/\/doi.org\/10.1186\/s12951-024-02921-7.","journal-title":"J Nanobiotechnol"},{"issue":"20","key":"4629_CR73","doi-asserted-by":"publisher","DOI":"10.1002\/adhm.201900826","volume":"8","author":"TY Yen","year":"2019","unstructured":"Yen TY, et al. Catalase-functionalized iron oxide nanoparticles reverse hypoxia-induced chemotherapeutic resistance. Adv Healthc Mater. 2019;8(20):e1900826. https:\/\/doi.org\/10.1002\/adhm.201900826.","journal-title":"Adv Healthc Mater"},{"key":"4629_CR74","doi-asserted-by":"publisher","DOI":"10.1002\/wnan.1464","author":"A Sen Gupta","year":"2017","unstructured":"Sen Gupta A. Bio-inspired nanomedicine strategies for artificial blood components. WIREs Nanomed Nanobiotechnol. 2017. https:\/\/doi.org\/10.1002\/wnan.1464.","journal-title":"WIREs Nanomed Nanobiotechnol"},{"key":"4629_CR75","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.jconrel.2019.12.028","volume":"319","author":"H Wang","year":"2020","unstructured":"Wang H, et al. Nanoparticles-mediated reoxygenation strategy relieves tumor hypoxia for enhanced cancer therapy. J Control Release. 2020;319:25\u201345. https:\/\/doi.org\/10.1016\/j.jconrel.2019.12.028.","journal-title":"J Control Release"},{"key":"4629_CR76","doi-asserted-by":"publisher","DOI":"10.3390\/nano15010037","author":"MH Chen","year":"2024","unstructured":"Chen MH, et al. Multifunctional nanoparticles as radiosensitizers to overcome hypoxia-associated resistance in cancer radiotherapy. Nanomaterials (Basel). 2024. https:\/\/doi.org\/10.3390\/nano15010037.","journal-title":"Nanomaterials (Basel)."},{"issue":"2","key":"4629_CR77","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1158\/0008-5472.Can-05-4005","volume":"66","author":"CE Lewis","year":"2006","unstructured":"Lewis CE, et al. Distinct role of macrophages in different tumor microenvironments. Cancer Res. 2006;66(2):605\u201312. https:\/\/doi.org\/10.1158\/0008-5472.Can-05-4005.","journal-title":"Cancer Res"},{"issue":"2","key":"4629_CR78","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.cell.2006.01.007","volume":"124","author":"J Condeelis","year":"2006","unstructured":"Condeelis J, et al. Macrophages: obligate partners for tumor cell migration, invasion, and metastasis. Cell. 2006;124(2):263\u20136. https:\/\/doi.org\/10.1016\/j.cell.2006.01.007.","journal-title":"Cell"},{"issue":"6","key":"4629_CR79","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1038\/s41577-019-0127-6","volume":"19","author":"DG DeNardo","year":"2019","unstructured":"DeNardo DG, et al. Macrophages as regulators of tumour immunity and immunotherapy. Nat Rev Immunol. 2019;19(6):369\u201382. https:\/\/doi.org\/10.1038\/s41577-019-0127-6.","journal-title":"Nat Rev Immunol"},{"issue":"40","key":"4629_CR80","doi-asserted-by":"publisher","DOI":"10.1002\/adma.202002054","volume":"32","author":"Y Xia","year":"2020","unstructured":"Xia Y, et al. Engineering macrophages for cancer immunotherapy and drug delivery. Adv Mater. 2020;32(40):e2002054. https:\/\/doi.org\/10.1002\/adma.202002054.","journal-title":"Adv Mater"},{"issue":"17","key":"4629_CR81","doi-asserted-by":"publisher","first-page":"11025","DOI":"10.1021\/acsnano.3c08335","volume":"18","author":"NK Horvat","year":"2024","unstructured":"Horvat NK, et al. Superparamagnetic iron oxide nanoparticles reprogram the tumor microenvironment and reduce lung cancer regrowth after crizotinib treatment. ACS Nano. 2024;18(17):11025\u201341. https:\/\/doi.org\/10.1021\/acsnano.3c08335.","journal-title":"ACS Nano"},{"issue":"11","key":"4629_CR82","doi-asserted-by":"publisher","first-page":"986","DOI":"10.1038\/nnano.2016.168","volume":"11","author":"S Zanganeh","year":"2016","unstructured":"Zanganeh S, et al. Iron oxide nanoparticles inhibit tumour growth by inducing pro-inflammatory macrophage polarization in tumour tissues. Nat Nanotechnol. 2016;11(11):986\u201394. https:\/\/doi.org\/10.1038\/nnano.2016.168.","journal-title":"Nat Nanotechnol"},{"issue":"4","key":"4629_CR83","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1016\/j.immuni.2018.03.017","volume":"48","author":"C Wang","year":"2018","unstructured":"Wang C, et al. Manganese increases the sensitivity of the cGAS-STING pathway for double-stranded DNA and is required for the host defense against DNA viruses. Immunity. 2018;48(4):675-687.e677. https:\/\/doi.org\/10.1016\/j.immuni.2018.03.017.","journal-title":"Immunity"},{"issue":"11","key":"4629_CR84","doi-asserted-by":"publisher","first-page":"1260","DOI":"10.1038\/s41565-021-00962-9","volume":"16","author":"X Sun","year":"2021","unstructured":"Sun X, et al. Amplifying STING activation by cyclic dinucleotide-manganese particles for local and systemic cancer metalloimmunotherapy. Nat Nanotechnol. 2021;16(11):1260\u201370. https:\/\/doi.org\/10.1038\/s41565-021-00962-9.","journal-title":"Nat Nanotechnol"},{"issue":"16","key":"4629_CR85","doi-asserted-by":"publisher","first-page":"15449","DOI":"10.1021\/acsnano.3c01215","volume":"17","author":"G Luo","year":"2023","unstructured":"Luo G, et al. Multifunctional calcium-manganese nanomodulator provides antitumor treatment and improved immunotherapy via reprogramming of the tumor microenvironment. ACS Nano. 2023;17(16):15449\u201365. https:\/\/doi.org\/10.1021\/acsnano.3c01215.","journal-title":"ACS Nano"},{"issue":"45","key":"4629_CR86","doi-asserted-by":"publisher","first-page":"14263","DOI":"10.1021\/acs.nanolett.4c03862","volume":"24","author":"X Wei","year":"2024","unstructured":"Wei X, et al. A multifunctional exosome with dual homeostasis disruption augments cGAS-STING-mediated tumor immunotherapy by boosting ferroptosis. Nano Lett. 2024;24(45):14263\u201372. https:\/\/doi.org\/10.1021\/acs.nanolett.4c03862.","journal-title":"Nano Lett"},{"issue":"15","key":"4629_CR87","doi-asserted-by":"publisher","DOI":"10.1002\/adma.201807211","volume":"31","author":"CX Li","year":"2019","unstructured":"Li CX, et al. Artificially reprogrammed macrophages as tumor-tropic immunosuppression-resistant biologics to realize therapeutics production and immune activation. Adv Mater. 2019;31(15):e1807211. https:\/\/doi.org\/10.1002\/adma.201807211.","journal-title":"Adv Mater"},{"key":"4629_CR88","doi-asserted-by":"publisher","DOI":"10.3390\/ijms222413346","author":"ZX Liao","year":"2021","unstructured":"Liao ZX, et al. Synergistic effect of repolarization of M2 to M1 macrophages induced by iron oxide nanoparticles combined with lactate oxidase. Int J Mol Sci. 2021. https:\/\/doi.org\/10.3390\/ijms222413346.","journal-title":"Int J Mol Sci"},{"issue":"8","key":"4629_CR89","doi-asserted-by":"publisher","first-page":"1336","DOI":"10.1039\/c4mt00104d","volume":"6","author":"E Gammella","year":"2014","unstructured":"Gammella E, et al. Macrophages: central regulators of iron balance. Metallomics. 2014;6(8):1336\u201345. https:\/\/doi.org\/10.1039\/c4mt00104d.","journal-title":"Metallomics"},{"key":"4629_CR90","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines9111585","author":"S Recalcati","year":"2021","unstructured":"Recalcati S, et al. Macrophages and iron: a special relationship. Biomedicines. 2021. https:\/\/doi.org\/10.3390\/biomedicines9111585.","journal-title":"Biomedicines"},{"issue":"30","key":"4629_CR91","doi-asserted-by":"publisher","first-page":"35906","DOI":"10.1021\/acsami.3c05555","volume":"15","author":"Y Portilla","year":"2023","unstructured":"Portilla Y, et al. Interaction of iron oxide nanoparticles with macrophages is influenced distinctly by \u201cSelf\u201d and \u201cNon-Self\u201d biological identities. ACS Appl Mater Interfaces. 2023;15(30):35906\u201326. https:\/\/doi.org\/10.1021\/acsami.3c05555.","journal-title":"ACS Appl Mater Interfaces"},{"issue":"4","key":"4629_CR92","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1016\/j.nano.2015.11.020","volume":"12","author":"JM Rojas","year":"2016","unstructured":"Rojas JM, et al. Superparamagnetic iron oxide nanoparticle uptake alters M2 macrophage phenotype, iron metabolism, migration and invasion. Nanomedicine. 2016;12(4):1127\u201338. https:\/\/doi.org\/10.1016\/j.nano.2015.11.020.","journal-title":"Nanomedicine"},{"issue":"1","key":"4629_CR93","doi-asserted-by":"publisher","DOI":"10.1080\/2162402x.2025.2571773","volume":"14","author":"L Laoubi","year":"2025","unstructured":"Laoubi L, et al. Dendritic cells: the central partner for cancer immunity. Oncoimmunology. 2025;14(1):2571773. https:\/\/doi.org\/10.1080\/2162402x.2025.2571773.","journal-title":"Oncoimmunology"},{"issue":"11","key":"4629_CR94","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2025.102412","volume":"6","author":"G Clayton","year":"2025","unstructured":"Clayton G, et al. Dendritic cell immunotherapy advances for solid tumors: vaccination and modulation. Cell Rep Med. 2025;6(11):102412. https:\/\/doi.org\/10.1016\/j.xcrm.2025.102412.","journal-title":"Cell Rep Med"},{"issue":"2","key":"4629_CR95","doi-asserted-by":"publisher","first-page":"2117","DOI":"10.1021\/acsnano.4c09525","volume":"19","author":"M-R Chiang","year":"2025","unstructured":"Chiang M-R, et al. Reprogramming dysfunctional dendritic cells by a versatile catalytic dual oxide antigen-captured nanosponge for remotely enhancing lung metastasis immunotherapy. ACS Nano. 2025;19(2):2117\u201335. https:\/\/doi.org\/10.1021\/acsnano.4c09525.","journal-title":"ACS Nano"},{"key":"4629_CR96","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1016\/j.jconrel.2023.05.028","volume":"358","author":"TMH Huynh","year":"2023","unstructured":"Huynh TMH, et al. Programmed antigen capture-harnessed dendritic cells by margination-hitchhiking lung delivery. J Control Release. 2023;358:718\u201328. https:\/\/doi.org\/10.1016\/j.jconrel.2023.05.028.","journal-title":"J Control Release"},{"issue":"22","key":"4629_CR97","doi-asserted-by":"publisher","DOI":"10.1002\/smll.202001704","volume":"16","author":"Q Jiang","year":"2020","unstructured":"Jiang Q, et al. Platelet membrane-camouflaged magnetic nanoparticles for ferroptosis-enhanced cancer immunotherapy. Small. 2020;16(22):e2001704. https:\/\/doi.org\/10.1002\/smll.202001704.","journal-title":"Small"},{"issue":"1","key":"4629_CR98","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-32645-x","volume":"13","author":"Y Zhang","year":"2022","unstructured":"Zhang Y, et al. Multifunctional nanoparticle potentiates the in situ vaccination effect of radiation therapy and enhances response to immune checkpoint blockade. Nat Commun. 2022;13(1):4948. https:\/\/doi.org\/10.1038\/s41467-022-32645-x.","journal-title":"Nat Commun"},{"issue":"1","key":"4629_CR99","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1111\/imr.12432","volume":"272","author":"A Alloatti","year":"2016","unstructured":"Alloatti A, et al. Dendritic cell maturation and cross-presentation: timing matters! Immunol Rev. 2016;272(1):97\u2013108. https:\/\/doi.org\/10.1111\/imr.12432.","journal-title":"Immunol Rev"},{"issue":"1","key":"4629_CR100","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1039\/d4na00561a","volume":"7","author":"M Song","year":"2024","unstructured":"Song M, et al. Dendritic cell activation by iron oxide nanoparticles depends on the extracellular environment. Nanoscale Adv. 2024;7(1):209\u201318. https:\/\/doi.org\/10.1039\/d4na00561a.","journal-title":"Nanoscale Adv"},{"issue":"15","key":"4629_CR101","doi-asserted-by":"publisher","first-page":"10509","DOI":"10.1021\/acsnano.3c12064","volume":"18","author":"P Korangath","year":"2024","unstructured":"Korangath P, et al. Iron oxide nanoparticles inhibit tumor progression and suppress lung metastases in mouse models of breast cancer. ACS Nano. 2024;18(15):10509\u201326. https:\/\/doi.org\/10.1021\/acsnano.3c12064.","journal-title":"ACS Nano"},{"issue":"38","key":"4629_CR102","doi-asserted-by":"publisher","first-page":"15812","DOI":"10.1021\/jacs.1c07471","volume":"143","author":"H Liang","year":"2021","unstructured":"Liang H, et al. Renal clearable ultrasmall single-crystal Fe nanoparticles for highly selective and effective ferroptosis therapy and immunotherapy. J Am Chem Soc. 2021;143(38):15812\u201323. https:\/\/doi.org\/10.1021\/jacs.1c07471.","journal-title":"J Am Chem Soc"},{"issue":"5","key":"4629_CR103","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1016\/j.cmet.2021.02.015","volume":"33","author":"X Ma","year":"2021","unstructured":"Ma X, et al. CD36-mediated ferroptosis dampens intratumoral CD8(+) T cell effector function and impairs their antitumor ability. Cell Metab. 2021;33(5):1001-1012.e1005. https:\/\/doi.org\/10.1016\/j.cmet.2021.02.015.","journal-title":"Cell Metab"},{"issue":"6","key":"4629_CR104","doi-asserted-by":"publisher","first-page":"2091","DOI":"10.1039\/d1nr06303k","volume":"14","author":"S Del Sol-Fern\u00e1ndez","year":"2022","unstructured":"Del Sol-Fern\u00e1ndez S, et al. Magnetogenetics: remote activation of cellular functions triggered by magnetic switches. Nanoscale. 2022;14(6):2091\u2013118. https:\/\/doi.org\/10.1039\/d1nr06303k.","journal-title":"Nanoscale"},{"issue":"21","key":"4629_CR105","doi-asserted-by":"publisher","first-page":"8116","DOI":"10.1021\/jacs.1c02537","volume":"143","author":"J Pan","year":"2021","unstructured":"Pan J, et al. Mild magnetic hyperthermia-activated innate immunity for liver cancer therapy. J Am Chem Soc. 2021;143(21):8116\u201328. https:\/\/doi.org\/10.1021\/jacs.1c02537.","journal-title":"J Am Chem Soc"},{"issue":"11","key":"4629_CR106","doi-asserted-by":"publisher","first-page":"1715","DOI":"10.2217\/nnm.14.106","volume":"9","author":"T Kobayashi","year":"2014","unstructured":"Kobayashi T, et al. Antitumor immunity by magnetic nanoparticle-mediated hyperthermia. Nanomedicine. 2014;9(11):1715\u201326. https:\/\/doi.org\/10.2217\/nnm.14.106.","journal-title":"Nanomedicine"},{"issue":"6","key":"4629_CR107","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1038\/nri3843","volume":"15","author":"SS Evans","year":"2015","unstructured":"Evans SS, et al. Fever and the thermal regulation of immunity: the immune system feels the heat. Nat Rev Immunol. 2015;15(6):335\u201349. https:\/\/doi.org\/10.1038\/nri3843.","journal-title":"Nat Rev Immunol"},{"issue":"6","key":"4629_CR108","doi-asserted-by":"publisher","first-page":"591","DOI":"10.3109\/02656736.2011.589234","volume":"27","author":"I Knippertz","year":"2011","unstructured":"Knippertz I, et al. Mild hyperthermia enhances human monocyte-derived dendritic cell functions and offers potential for applications in vaccination strategies. Int J Hyperthermia. 2011;27(6):591\u2013603. https:\/\/doi.org\/10.3109\/02656736.2011.589234.","journal-title":"Int J Hyperthermia"},{"key":"4629_CR109","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.595207","volume":"11","author":"Z Li","year":"2020","unstructured":"Li Z, et al. Hyperthermia targeting the tumor microenvironment facilitates immune checkpoint inhibitors. Front Immunol. 2020;11:595207. https:\/\/doi.org\/10.3389\/fimmu.2020.595207.","journal-title":"Front Immunol"},{"issue":"1","key":"4629_CR110","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41435-021-00161-5","volume":"23","author":"B Decraene","year":"2022","unstructured":"Decraene B, et al. Immunogenic cell death and its therapeutic or prognostic potential in high-grade glioma. Genes Immun. 2022;23(1):1\u201311. https:\/\/doi.org\/10.1038\/s41435-021-00161-5.","journal-title":"Genes Immun"},{"issue":"8","key":"4629_CR111","doi-asserted-by":"publisher","first-page":"2215","DOI":"10.1007\/s00330-013-2825-y","volume":"23","author":"GC van Rhoon","year":"2013","unstructured":"van Rhoon GC, et al. CEM43\u00b0C thermal dose thresholds: a potential guide for magnetic resonance radiofrequency exposure levels? Eur Radiol. 2013;23(8):2215\u201327. https:\/\/doi.org\/10.1007\/s00330-013-2825-y.","journal-title":"Eur Radiol"},{"issue":"2","key":"4629_CR112","doi-asserted-by":"publisher","first-page":"89","DOI":"10.5001\/omj.2016.19","volume":"31","author":"Z Behrouzkia","year":"2016","unstructured":"Behrouzkia Z, et al. Hyperthermia: how can it be used? Oman Med J. 2016;31(2):89\u201397. https:\/\/doi.org\/10.5001\/omj.2016.19.","journal-title":"Oman Med J"},{"key":"4629_CR113","doi-asserted-by":"publisher","DOI":"10.3389\/fceld.2024.1465506","volume":"3","author":"A Enomoto","year":"2024","unstructured":"Enomoto A, et al. Hyperthermia-mediated cell death via deregulation of extracellular signal-regulated kinase and c-Jun NH2-terminal kinase signaling. Front Cell Death. 2024;3:1465506. https:\/\/doi.org\/10.3389\/fceld.2024.1465506.","journal-title":"Front Cell Death"},{"issue":"21","key":"4629_CR114","doi-asserted-by":"publisher","DOI":"10.3390\/cancers16213656","volume":"16","author":"L Van Dieren","year":"2024","unstructured":"Van Dieren L, et al. Combined radiotherapy and hyperthermia: a systematic review of immunological synergies for amplifying radiation-induced abscopal effects. Cancers (Basel). 2024;16(21):3656. https:\/\/doi.org\/10.3390\/cancers16213656.","journal-title":"Cancers (Basel)"},{"key":"4629_CR115","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.jconrel.2020.01.009","volume":"320","author":"LL Israel","year":"2020","unstructured":"Israel LL, et al. Magnetic iron oxide nanoparticles for imaging, targeting and treatment of primary and metastatic tumors of the brain. J Control Release. 2020;320:45\u201362. https:\/\/doi.org\/10.1016\/j.jconrel.2020.01.009.","journal-title":"J Control Release"},{"issue":"3","key":"4629_CR116","doi-asserted-by":"publisher","DOI":"10.1007\/s41061-020-00302-w","volume":"378","author":"A Avasthi","year":"2020","unstructured":"Avasthi A, et al. Magnetic nanoparticles as MRI contrast agents. Top Curr Chem. 2020;378(3):40. https:\/\/doi.org\/10.1007\/s41061-020-00302-w.","journal-title":"Top Curr Chem"},{"issue":"1","key":"4629_CR117","doi-asserted-by":"publisher","DOI":"10.1103\/PhysRevApplied.19.014055","volume":"19","author":"D Chalise","year":"2023","unstructured":"Chalise D, et al. Highly sensitive and high-throughput magnetic resonance thermometry of fluids using superparamagnetic nanoparticles. Phys Rev Appl. 2023;19(1):014055. https:\/\/doi.org\/10.1103\/PhysRevApplied.19.014055.","journal-title":"Phys Rev Appl"},{"issue":"47","key":"4629_CR118","doi-asserted-by":"publisher","DOI":"10.1002\/adma.202504404","volume":"37","author":"R Gao","year":"2025","unstructured":"Gao R, et al. An intracellular magnetic micromotor drives spatiotemporal mechano-immunotherapy. Adv Mater. 2025;37(47):e04404. https:\/\/doi.org\/10.1002\/adma.202504404.","journal-title":"Adv Mater"},{"issue":"3","key":"4629_CR119","doi-asserted-by":"publisher","DOI":"10.3390\/cancers17030515","volume":"17","author":"PC Guillemin","year":"2025","unstructured":"Guillemin PC, et al. Using the tissue impulse response function to streamline fractionated MRgFUS-induced hyperthermia. Cancers (Basel). 2025;17(3):515. https:\/\/doi.org\/10.3390\/cancers17030515.","journal-title":"Cancers (Basel)"},{"issue":"5","key":"4629_CR120","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1097\/rli.0000000000001030","volume":"59","author":"R Roudi","year":"2024","unstructured":"Roudi R, et al. Novel clinically translatable iron oxide nanoparticle for monitoring anti-CD47 cancer immunotherapy. Invest Radiol. 2024;59(5):391\u2013403. https:\/\/doi.org\/10.1097\/rli.0000000000001030.","journal-title":"Invest Radiol"},{"issue":"1","key":"4629_CR121","doi-asserted-by":"publisher","DOI":"10.1016\/j.magmed.2025.100002","volume":"1","author":"Y Huang","year":"2025","unstructured":"Huang Y, et al. The metabolic fate of iron-based magnetic nanomaterials and their impact on macrophage function. Magnetic Medicine. 2025;1(1):100002. https:\/\/doi.org\/10.1016\/j.magmed.2025.100002.","journal-title":"Magnetic Medicine"},{"issue":"23","key":"4629_CR122","doi-asserted-by":"publisher","first-page":"8576","DOI":"10.1039\/c5cs00541h","volume":"44","author":"H Arami","year":"2015","unstructured":"Arami H, et al. In vivo delivery, pharmacokinetics, biodistribution and toxicity of iron oxide nanoparticles. Chem Soc Rev. 2015;44(23):8576\u2013607. https:\/\/doi.org\/10.1039\/c5cs00541h.","journal-title":"Chem Soc Rev"},{"key":"4629_CR123","doi-asserted-by":"publisher","DOI":"10.1002\/smll.201602030","author":"J Volatron","year":"2017","unstructured":"Volatron J, et al. Ferritin protein regulates the degradation of iron oxide nanoparticles. Small. 2017. https:\/\/doi.org\/10.1002\/smll.201602030.","journal-title":"Small"},{"issue":"3","key":"4629_CR124","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1080\/17435390.2021.1872112","volume":"15","author":"J Gao","year":"2021","unstructured":"Gao J, et al. Time-course effect of ultrasmall superparamagnetic iron oxide nanoparticles on intracellular iron metabolism and ferroptosis activation. Nanotoxicology. 2021;15(3):366\u201379. https:\/\/doi.org\/10.1080\/17435390.2021.1872112.","journal-title":"Nanotoxicology"},{"key":"4629_CR125","doi-asserted-by":"publisher","DOI":"10.1172\/jci148671","author":"N Koleini","year":"2021","unstructured":"Koleini N, et al. Ironing out mechanisms of iron homeostasis and disorders of iron deficiency. J Clin Invest. 2021. https:\/\/doi.org\/10.1172\/jci148671.","journal-title":"J Clin Invest"},{"issue":"5","key":"4629_CR126","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics15051475","volume":"15","author":"M Kluknavsky","year":"2023","unstructured":"Kluknavsky M, et al. A single infusion of polyethylene glycol-coated superparamagnetic magnetite nanoparticles alters differently the expressions of genes involved in iron metabolism in the liver and heart of rats. Pharmaceutics. 2023;15(5):1475. https:\/\/doi.org\/10.3390\/pharmaceutics15051475.","journal-title":"Pharmaceutics"},{"key":"4629_CR127","doi-asserted-by":"publisher","unstructured":"Singh N, et al. Potential toxicity of superparamagnetic iron oxide nanoparticles (SPION). Nano Rev. 2010;1. https:\/\/doi.org\/10.3402\/nano.v1i0.5358.","DOI":"10.3402\/nano.v1i0.5358"},{"issue":"9\u201310","key":"4629_CR128","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.1080\/17435390.2017.1408151","volume":"11","author":"K Matusiak","year":"2017","unstructured":"Matusiak K, et al. The elemental changes occurring in the rat liver after exposure to PEG-coated iron oxide nanoparticles: total reflection x-ray fluorescence (TXRF) spectroscopy study. Nanotoxicology. 2017;11(9\u201310):1225\u201336. https:\/\/doi.org\/10.1080\/17435390.2017.1408151.","journal-title":"Nanotoxicology"},{"key":"4629_CR129","doi-asserted-by":"publisher","first-page":"2071","DOI":"10.2147\/ijn.S402320","volume":"18","author":"H Unterweger","year":"2023","unstructured":"Unterweger H, et al. Comparative in vitro and in vivo evaluation of different iron oxide-based contrast agents to promote clinical translation in compliance with patient safety. Int J Nanomedicine. 2023;18:2071\u201386. https:\/\/doi.org\/10.2147\/ijn.S402320.","journal-title":"Int J Nanomedicine"},{"issue":"5","key":"4629_CR130","doi-asserted-by":"publisher","first-page":"3939","DOI":"10.1021\/nn305719y","volume":"7","author":"L Lartigue","year":"2013","unstructured":"Lartigue L, et al. Biodegradation of iron oxide nanocubes: high-resolution in situ monitoring. ACS Nano. 2013;7(5):3939\u201352. https:\/\/doi.org\/10.1021\/nn305719y.","journal-title":"ACS Nano"},{"issue":"1","key":"4629_CR131","doi-asserted-by":"publisher","DOI":"10.1186\/s12951-022-01747-5","volume":"20","author":"Y Portilla","year":"2022","unstructured":"Portilla Y, et al. Different coatings on magnetic nanoparticles dictate their degradation kinetics in vivo for 15 months after intravenous administration in mice. J Nanobiotechnol. 2022;20(1):543. https:\/\/doi.org\/10.1186\/s12951-022-01747-5.","journal-title":"J Nanobiotechnol"},{"issue":"5","key":"4629_CR132","doi-asserted-by":"publisher","DOI":"10.1038\/natrevmats.2016.14","volume":"1","author":"S Wilhelm","year":"2016","unstructured":"Wilhelm S, et al. Analysis of nanoparticle delivery to tumours. Nat Rev Mater. 2016;1(5):16014. https:\/\/doi.org\/10.1038\/natrevmats.2016.14.","journal-title":"Nat Rev Mater"},{"issue":"3","key":"4629_CR133","doi-asserted-by":"publisher","first-page":"3075","DOI":"10.1021\/acsnano.9b08142","volume":"14","author":"YH Cheng","year":"2020","unstructured":"Cheng YH, et al. Meta-analysis of nanoparticle delivery to tumors using a physiologically based pharmacokinetic modeling and simulation approach. ACS Nano. 2020;14(3):3075\u201395. https:\/\/doi.org\/10.1021\/acsnano.9b08142.","journal-title":"ACS Nano"},{"issue":"2","key":"4629_CR134","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1038\/s41573-020-0090-8","volume":"20","author":"MJ Mitchell","year":"2021","unstructured":"Mitchell MJ, et al. Engineering precision nanoparticles for drug delivery. Nat Rev Drug Discov. 2021;20(2):101\u201324. https:\/\/doi.org\/10.1038\/s41573-020-0090-8.","journal-title":"Nat Rev Drug Discov"},{"issue":"8","key":"4629_CR135","doi-asserted-by":"publisher","first-page":"8423","DOI":"10.1021\/acsnano.8b03900","volume":"12","author":"Q Dai","year":"2018","unstructured":"Dai Q, et al. Quantifying the ligand-coated nanoparticle delivery to cancer cells in solid tumors. ACS Nano. 2018;12(8):8423\u201335. https:\/\/doi.org\/10.1021\/acsnano.8b03900.","journal-title":"ACS Nano"},{"issue":"1","key":"4629_CR136","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-54810-0","volume":"15","author":"Y Li","year":"2024","unstructured":"Li Y, et al. Specific surface-modified iron oxide nanoparticles trigger complement-dependent innate and adaptive antileukaemia immunity. Nat Commun. 2024;15(1):10400. https:\/\/doi.org\/10.1038\/s41467-024-54810-0.","journal-title":"Nat Commun"},{"issue":"3","key":"4629_CR137","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1007\/s13346-022-01252-0","volume":"13","author":"H Liu","year":"2023","unstructured":"Liu H, et al. Cell membrane-coated nanoparticles: a novel multifunctional biomimetic drug delivery system. Drug Deliv Transl Res. 2023;13(3):716\u201337. https:\/\/doi.org\/10.1007\/s13346-022-01252-0.","journal-title":"Drug Deliv Transl Res"},{"issue":"4","key":"4629_CR138","doi-asserted-by":"publisher","first-page":"393","DOI":"10.7150\/ntno.84255","volume":"7","author":"S Healy","year":"2023","unstructured":"Healy S, et al. Spatial analysis of nanoparticle distribution in human breast xenografts reveals nanoparticles targeted to cancer cells localized with tumor-associated stromal cells. Nanotheranostics. 2023;7(4):393\u2013411. https:\/\/doi.org\/10.7150\/ntno.84255.","journal-title":"Nanotheranostics"},{"issue":"11","key":"4629_CR139","doi-asserted-by":"publisher","first-page":"1597","DOI":"10.1038\/s41565-024-01754-7","volume":"19","author":"P Joyce","year":"2024","unstructured":"Joyce P, et al. A translational framework to DELIVER nanomedicines to the clinic. Nat Nanotechnol. 2024;19(11):1597\u2013611. https:\/\/doi.org\/10.1038\/s41565-024-01754-7.","journal-title":"Nat Nanotechnol"},{"issue":"12","key":"4629_CR140","doi-asserted-by":"publisher","DOI":"10.1002\/adhm.202000110","volume":"9","author":"DM Valcourt","year":"2020","unstructured":"Valcourt DM, et al. Best practices for preclinical in vivo testing of cancer nanomedicines. Advanced Healthcare Materials. 2020;9(12):e2000110. https:\/\/doi.org\/10.1002\/adhm.202000110.","journal-title":"Advanced Healthcare Materials"},{"issue":"1","key":"4629_CR141","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-023-01419-2","volume":"8","author":"Y Liu","year":"2023","unstructured":"Liu Y, et al. Patient-derived xenograft models in cancer therapy: technologies and applications. Signal Transduct Target Ther. 2023;8(1):160. https:\/\/doi.org\/10.1038\/s41392-023-01419-2.","journal-title":"Signal Transduct Target Ther"},{"issue":"7","key":"4629_CR142","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1016\/j.trecan.2023.03.009","volume":"9","author":"M Bosenberg","year":"2023","unstructured":"Bosenberg M, et al. Mouse models for immuno-oncology. Trends Cancer. 2023;9(7):578\u201390. https:\/\/doi.org\/10.1016\/j.trecan.2023.03.009.","journal-title":"Trends Cancer"},{"issue":"1","key":"4629_CR143","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1038\/s41565-020-00817-9","volume":"16","author":"W Jiang","year":"2021","unstructured":"Jiang W, et al. Considerations for designing preclinical cancer immune nanomedicine studies. Nat Nanotechnol. 2021;16(1):6\u201315. https:\/\/doi.org\/10.1038\/s41565-020-00817-9.","journal-title":"Nat Nanotechnol"},{"issue":"11","key":"4629_CR144","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1038\/s41568-020-0285-7","volume":"20","author":"D Bruni","year":"2020","unstructured":"Bruni D, et al. The immune contexture and immunoscore in cancer prognosis and therapeutic efficacy. Nat Rev Cancer. 2020;20(11):662\u201380. https:\/\/doi.org\/10.1038\/s41568-020-0285-7.","journal-title":"Nat Rev Cancer"},{"issue":"4","key":"4629_CR145","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1038\/s41571-019-0308-z","volume":"17","author":"JD Martin","year":"2020","unstructured":"Martin JD, et al. Improving cancer immunotherapy using nanomedicines: progress, opportunities and challenges. Nat Rev Clin Oncol. 2020;17(4):251\u201366. https:\/\/doi.org\/10.1038\/s41571-019-0308-z.","journal-title":"Nat Rev Clin Oncol"},{"issue":"11","key":"4629_CR146","doi-asserted-by":"publisher","first-page":"5365","DOI":"10.7150\/thno.58390","volume":"11","author":"YT Liu","year":"2021","unstructured":"Liu YT, et al. Turning cold tumors into hot tumors by improving T-cell infiltration. Theranostics. 2021;11(11):5365\u201386. https:\/\/doi.org\/10.7150\/thno.58390.","journal-title":"Theranostics"},{"issue":"1","key":"4629_CR147","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-49885-8","volume":"15","author":"A Coulton","year":"2024","unstructured":"Coulton A, et al. Using a pan-cancer atlas to investigate tumour associated macrophages as regulators of immunotherapy response. Nat Commun. 2024;15(1):5665. https:\/\/doi.org\/10.1038\/s41467-024-49885-8.","journal-title":"Nat Commun"},{"issue":"6","key":"4629_CR148","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1038\/s41578-019-0108-1","volume":"4","author":"J Nam","year":"2019","unstructured":"Nam J, et al. Cancer nanomedicine for combination cancer immunotherapy. Nat Rev Mater. 2019;4(6):398\u2013414. https:\/\/doi.org\/10.1038\/s41578-019-0108-1.","journal-title":"Nat Rev Mater"},{"key":"4629_CR149","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/j.jconrel.2021.01.009","volume":"331","author":"M Kwon","year":"2021","unstructured":"Kwon M, et al. The right timing, right combination, right sequence, and right delivery for cancer immunotherapy. J Control Release. 2021;331:321\u201334. https:\/\/doi.org\/10.1016\/j.jconrel.2021.01.009.","journal-title":"J Control Release"},{"key":"4629_CR150","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2024.108631","volume":"257","author":"SM Stribbling","year":"2024","unstructured":"Stribbling SM, et al. Orthotopic and metastatic tumour models in preclinical cancer research. Pharmacol Ther. 2024;257:108631. https:\/\/doi.org\/10.1016\/j.pharmthera.2024.108631.","journal-title":"Pharmacol Ther"},{"issue":"1","key":"4629_CR151","doi-asserted-by":"publisher","DOI":"10.1002\/wnan.1739","volume":"14","author":"CE Boone","year":"2022","unstructured":"Boone CE, et al. Combining nanomedicine and immune checkpoint therapy for cancer immunotherapy. WIREs Nanomed Nanobiotechnol. 2022;14(1):e1739. https:\/\/doi.org\/10.1002\/wnan.1739.","journal-title":"WIREs Nanomed Nanobiotechnol"},{"key":"4629_CR152","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/bs.acr.2015.05.001","volume":"128","author":"JD Peske","year":"2015","unstructured":"Peske JD, et al. Control of CD8 T-cell infiltration into tumors by vasculature and microenvironment. Adv Cancer Res. 2015;128:263\u2013307. https:\/\/doi.org\/10.1016\/bs.acr.2015.05.001.","journal-title":"Adv Cancer Res"},{"issue":"1","key":"4629_CR153","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1038\/s41416-018-0327-z","volume":"120","author":"NA Giraldo","year":"2019","unstructured":"Giraldo NA, et al. The clinical role of the TME in solid cancer. Br J Cancer. 2019;120(1):45\u201353. https:\/\/doi.org\/10.1038\/s41416-018-0327-z.","journal-title":"Br J Cancer"},{"issue":"8","key":"4629_CR154","doi-asserted-by":"publisher","first-page":"1288","DOI":"10.1158\/2767-9764.Crc-25-0268","volume":"5","author":"Z Zhou","year":"2025","unstructured":"Zhou Z, et al. Evaluation of ferroptosis as a biomarker to predict treatment outcomes of cancer immunotherapy. Cancer Res Commun. 2025;5(8):1288\u201397. https:\/\/doi.org\/10.1158\/2767-9764.Crc-25-0268.","journal-title":"Cancer Res Commun"},{"key":"4629_CR155","volume-title":"FERABRIGHT (ferumoxytol injection) [prescribing information]","author":"U.S. Food and Drug Administration","year":"2025","unstructured":"U.S. Food and Drug Administration. FERABRIGHT (ferumoxytol injection) [prescribing information]. U.S. Food and Drug Administration; 2025."},{"key":"4629_CR156","doi-asserted-by":"publisher","DOI":"10.1016\/j.addr.2025.115756","volume":"229","author":"Y Li","year":"2026","unstructured":"Li Y, et al. Clinical translation and landscape of superparamagnetic iron oxide nanoparticles. Adv Drug Deliv Rev. 2026;229:115756. https:\/\/doi.org\/10.1016\/j.addr.2025.115756.","journal-title":"Adv Drug Deliv Rev"},{"key":"4629_CR157","doi-asserted-by":"publisher","DOI":"10.3390\/ph17030300","author":"B Rodriguez","year":"2024","unstructured":"Rodriguez B, et al. Magnetic hyperthermia therapy for high-grade glioma: a state-of-the-art review. Pharmaceuticals (Basel). 2024. https:\/\/doi.org\/10.3390\/ph17030300.","journal-title":"Pharmaceuticals (Basel)"},{"key":"4629_CR158","doi-asserted-by":"publisher","DOI":"10.1016\/j.jconrel.2025.113991","volume":"385","author":"RM Pallares","year":"2025","unstructured":"Pallares RM, et al. Clinical cancer nanomedicines. J Control Release. 2025;385:113991. https:\/\/doi.org\/10.1016\/j.jconrel.2025.113991.","journal-title":"J Control Release"},{"issue":"1","key":"4629_CR159","doi-asserted-by":"publisher","DOI":"10.1136\/bmjonc-2024-000573","volume":"4","author":"AA Gabizon","year":"2025","unstructured":"Gabizon AA, et al. Thirty years from FDA approval of pegylated liposomal doxorubicin (Doxil\/Caelyx): an updated analysis and future perspective. BMJ Oncol. 2025;4(1):e000573. https:\/\/doi.org\/10.1136\/bmjonc-2024-000573.","journal-title":"BMJ Oncol"},{"key":"4629_CR160","volume-title":"Feraheme (ferumoxytol injection) [prescribing information]","author":"AMAG Pharmaceuticals, Inc.","year":"2022","unstructured":"AMAG Pharmaceuticals, Inc. Feraheme (ferumoxytol injection) [prescribing information]. Waltham, MA: AMAG Pharmaceuticals, Inc.; 2022."},{"issue":"1","key":"4629_CR161","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1080\/02656736.2020.1779357","volume":"37","author":"HP Kok","year":"2020","unstructured":"Kok HP, et al. Heating technology for malignant tumors: a review. Int J Hyperthermia. 2020;37(1):711\u201341. https:\/\/doi.org\/10.1080\/02656736.2020.1779357.","journal-title":"Int J Hyperthermia"}],"container-title":["Journal of Nanobiotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12951-026-04629-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-026-04629-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-026-04629-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T16:55:51Z","timestamp":1785776151000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12951-026-04629-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,4]]},"references-count":161,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4629"],"URL":"https:\/\/doi.org\/10.1186\/s12951-026-04629-2","relation":{},"ISSN":["1477-3155"],"issn-type":[{"value":"1477-3155","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,4]]},"assertion":[{"value":"11 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","label":"Ethics approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"708"}}